What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?

Affiliations

¹ Department of Molecular Medicine, Jamia Hamdard Institute of Molecular Medicine, Jamia Hamdard (Deemed-to-be-University), New Delhi; Departments of General Medicine & Respiratory Medicine, Jawaharlal Nehru Medical College (JNMC), Datta Meghe Institute of Medical Science, Wardha, India.
² Department of Medicine & UCT Lung Institute, Division of Pulmonology, Centre for Lung Infection & Immunity, University of Cape Town, Cape Town, South Africa; Department of Immunology & Infection, Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.

Editorial

Surendra K Sharma et al. Indian J Med Res. 2019 Mar.

. 2019 Mar;149(3):309-312.

doi: 10.4103/ijmr.IJMR_579_19.

¹ Department of Molecular Medicine, Jamia Hamdard Institute of Molecular Medicine, Jamia Hamdard (Deemed-to-be-University), New Delhi; Departments of General Medicine & Respiratory Medicine, Jawaharlal Nehru Medical College (JNMC), Datta Meghe Institute of Medical Science, Wardha, India.
² Department of Medicine & UCT Lung Institute, Division of Pulmonology, Centre for Lung Infection & Immunity, University of Cape Town, Cape Town, South Africa; Department of Immunology & Infection, Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.

No abstract available

Conflict of interest statement

None

1. World Health Organization. Global Tuberculosis Report 2018. Geneva: WHO; 2018.
1. Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 2017 pii: S2213-2600(17)30079-6. - PubMed
1. Pietersen E, Ignatius E, Streicher EM, Mastrapa B, Padanilam X, Pooran A, et al. Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: A cohort study. Lancet. 2014;383:1230–9. - PubMed
1. Reuter A, Tisile P, von Delft D, Cox H, Cox V, Ditiu L, et al. The devil we know: Is the use of injectable agents for the treatment of MDR-TB justified? Int J Tuberc Lung Dis. 2017;21:1114–26. - PubMed
1. Central TB Division. Guidelines on programmatic management of drug resistant TB (PMDT) in India. Revised national tuberculosis control programme. New Delhi: Directorate-General of Health Services, Ministry of Health & Family Welfare, Government of India; 2017. [accessed on January 30, 2019]. Available from: https://tbcindia.gov.in/index1.php?lang=1&level=2&sublinkid=4781&lid=3306 .